US88025U1097
US88025U1097
10x Genomics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 642.823.000 | 610.785.000 | 5.2% |
| Cost of Revenue | 198.942.000 | 196.303.000 | 1.3% |
| Gross Profit | 443.881.000 | 414.482.000 | 7.1% |
| 554.766.000 | 609.041.000 | 8.9% | |
| Operating Income | -110.885.000 | -194.559.000 | 43.0% |
| Pretax Income | -39.907.000 | -177.700.000 | 77.5% |
| Net Income Common Stockholders | -43.544.000 | -182.627.000 | 76.2% |
| -- | -- | -- | |
| -- | -- | -- |